FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
MONARCH CASINO & RESORT INC [ MCRI ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 05/05/2021 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 05/05/2021 | S | 17,346 | D | $73.184 | 60,450 | D |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Options / Right to Buy | $60.62 | 03/31/2024 | 03/31/2031 | Common Stock | 15,000 | 164,999 | D | ||||||||
Options / Right to Buy | (1) | (1) | (1) | Common Stock | 33,333 | 164,999 | D | ||||||||
Options / Right to Buy | (2) | (2) | (2) | Common Stock | 33,333 | 164,999 | D | ||||||||
Options / Right to Buy | (3) | (3) | (3) | Common Stock | 83,333 | 164,999 | D |
Explanation of Responses: |
1. In 2020 Mr. Farahi was granted 33,333 stock options, as follow: (i) 13,333 stock options at $53.680 exercise price, which vest on February 1, 2023; (ii) 1,667 stock options at $47.28 exercise price, which vest on March 1, 2023; and (iii) 18,333 stock options at $44.60 exercise price, which vest on September 30, 2023. All stock options expire 10 years from the grant date, or approximately 7 years from the vesting date. |
2. In 2019 Mr. Farahi was granted 33,333 stock options, as follow: (i) 13,334 stock options at $43.30 exercise price, which vest on February 1, 2022; (ii) 1,666 stock options at $44.31 exercise price, which vest on March 1, 2022; (iii) 6,666 stock options at $45.69 exercise price, which vest on August 1, 2022 and (v) 11,667 stock options at $44.38 exercise price, which vest on September 1, 2022. All stock options expire 10 years from the grant date, or approximately 7 years from the vesting date. |
3. In 2018 Mr. Farahi was granted 83,333 stock options, as follow: (i) 13,333 stock options at $45.55 exercise price, which vested on February 1, 2021; (ii) 1,667 stock options at $42.46 exercise price, which vested on March 1, 2021; (iii) 50,000 stock options at $42.74 exercise price, of which 16,666 vested on May 3, 2021, 16,667 vest on May 3, 2022 and 16,667 vest on May 3, 2023; (iv) 6,667 stock options at $47.81 exercise price, which vest on August 1, 2021 and (v) 11,666 stock options at $47.05 exercise price, which vest on September 1, 2021. All stock options expire 10 years from the grant date, or approximately 7 years from the vesting date. |
David Farahi | 05/07/2021 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |